BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 12589104)

  • 41. Cancer-free survival of psoriasis patients treated with methotrexate and cyclosporine combination.
    Aydin F; Yuksel EP; Senturk N; Canturk T; Turanli AY
    Cutan Ocul Toxicol; 2014 Sep; 33(3):181-3. PubMed ID: 23944659
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Systemic immunomodulatory therapy in severe dry eye secondary to inflammation.
    Cordero-Coma M; Anzaar F; Sobrin L; Foster CS
    Ocul Immunol Inflamm; 2007; 15(2):99-104. PubMed ID: 17558834
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Species-specific immune responses generated by histidyl-tRNA synthetase immunization are associated with muscle and lung inflammation.
    Katsumata Y; Ridgway WM; Oriss T; Gu X; Chin D; Wu Y; Fertig N; Oury T; Vandersteen D; Clemens P; Camacho CJ; Weinberg A; Ascherman DP
    J Autoimmun; 2007; 29(2-3):174-86. PubMed ID: 17826948
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Current approach to the treatment of polymyositis and dermatomyositis.
    Oddis CV
    Curr Opin Rheumatol; 2000 Nov; 12(6):492-7. PubMed ID: 11092197
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Immunologic tests: Anti-Jo-l antibody (anti-histidyl transfer RNA synthetase antibody)].
    Katsuki Y; Hirakata M
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():505-7. PubMed ID: 16111315
    [No Abstract]   [Full Text] [Related]  

  • 46. [Anti-synthetase syndrome: a special subgroup of idiopathic inflammatory myopathies. Apropos of 3 case reports].
    Perret L; Salani I; Rivier G; So AK
    Praxis (Bern 1994); 1996 Apr; 85(16):508-12. PubMed ID: 8657993
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Anti-Jo-1-positive polymyositis with interstitial alveolitis and pericardial effusion. Overview of 3 years treatment].
    Krajnc I
    Wien Klin Wochenschr; 1995; 107(19):590-2. PubMed ID: 7502505
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cyclosporine treatment for dermatomyositis/polymyositis.
    Mehregan DR; Su WP
    Cutis; 1993 Jan; 51(1):59-61. PubMed ID: 8419114
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CD25 blockade for refractory polymyositis.
    Pipitone N; Salvarani C
    Clin Exp Rheumatol; 2013; 31(3):474. PubMed ID: 23465197
    [No Abstract]   [Full Text] [Related]  

  • 50. Drug treatment of polymyositis and dermatomyositis.
    Murthy JM
    Neurol India; 2010; 58(1):3-5. PubMed ID: 20228455
    [No Abstract]   [Full Text] [Related]  

  • 51. Anti-Jo-1 antibody in patients with polymyositis/dermatomyositis.
    Leu CC; Lan JL
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1992 Feb; 25(1):41-7. PubMed ID: 1306148
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cyclosporine and methotrexate for severe rheumatoid arthritis.
    Storb R; Thomas ED
    N Engl J Med; 1995 Dec; 333(23):1568; author reply 1568-9. PubMed ID: 7477182
    [No Abstract]   [Full Text] [Related]  

  • 53. Anti-Jo-1 antibodies.
    Zampieri S; Ghirardello A; Iaccarino L; Tarricone E; Gambari PF; Doria A
    Autoimmunity; 2005 Feb; 38(1):73-8. PubMed ID: 15804708
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Possible role for tumour necrosis factor inhibitors in the treatment of resistant dermatomyositis and polymyositis: a retrospective study of eight patients.
    Efthimiou P; Schwartzman S; Kagen LJ
    Ann Rheum Dis; 2006 Sep; 65(9):1233-6. PubMed ID: 16476710
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Idiopathic inflammatory myopathies from the viewpoint of rheumatologists].
    Gono T; Katsumata Y; Kawaguchi Y
    Brain Nerve; 2013 Nov; 65(11):1275-82. PubMed ID: 24200605
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The anti-synthetase syndrome].
    Bergoin C; Bure M; Tavernier JY; Lamblin C; Maurage CA; Remy-Jardin M; Wallaert B
    Rev Mal Respir; 2002 Jun; 19(3):371-4. PubMed ID: 12161705
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Etanercept-induced anti-Jo-1-antibody-positive polymyositis in a patient with rheumatoid arthritis: a case report and review of the literature.
    Ishikawa Y; Yukawa N; Ohmura K; Hosono Y; Imura Y; Kawabata D; Nojima T; Fujii T; Usui T; Mimori T
    Clin Rheumatol; 2010 May; 29(5):563-6. PubMed ID: 20143116
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Successful therapy with cyclosporine in a case with interstitial pneumonitis associated with polymyositis].
    Soga T; Hagiwara E; Shirai A; Igarashi T; Ishigatsubo Y; Okubo T
    Nihon Rinsho Meneki Gakkai Kaishi; 1996 Apr; 19(2):157-62. PubMed ID: 8705693
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Successful treatment of refractory polymyositis with pulse intravenous cyclophosphamide and low-dose weekly oral methotrexate therapy.
    Hirano F; Tanaka H; Nomura Y; Matsui T; Makino Y; Fukawa E; Miura T; Makino I
    Intern Med; 1993 Sep; 32(9):749-52. PubMed ID: 8142684
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of refractory polymyositis and dermatomyositis.
    Ytterberg SR
    Curr Rheumatol Rep; 2006 Jun; 8(3):167-73. PubMed ID: 16901073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.